{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:48Z","timestamp":1786980288060,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00520-015-2908-1","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T02:40:02Z","timestamp":1441075202000},"page":"1327-1337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases"],"prefix":"10.1007","volume":"24","author":[{"given":"Roger","family":"von Moos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Body","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair","family":"Egerdie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Stopeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Fallowfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Cleeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danail","family":"Damyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Salvador","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Balakumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"issue":"3","key":"2908_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","volume":"27","author":"RE Coleman","year":"2001","unstructured":"Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27(3):165\u2013176","journal-title":"Cancer Treat Rev"},{"issue":"20 Pt 2","key":"2908_CR2","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12(20 Pt 2):6243s\u20136249s","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2908_CR3","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00520-013-1755-1","volume":"21","author":"R Moos von","year":"2013","unstructured":"von Moos R, Sternberg C, Body JJ, Bokemeyer C (2013) Reducing the burden of bone metastases: current concepts and treatment options. Support Care Cancer 21(6):1773\u20131783","journal-title":"Support Care Cancer"},{"issue":"12","key":"2908_CR4","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1093\/annonc\/mds175","volume":"23","author":"S Vadhan-Raj","year":"2012","unstructured":"Vadhan-Raj S, von Moos R, Fallowfield LJ, Patrick DL, Goldwasser F, Cleeland CS, Henry DH, Novello S, Hungria V, Qian Y, Feng A, Yeh H, Chung K (2012) Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. Ann Oncol 23(12):3045\u20133051","journal-title":"Ann Oncol"},{"issue":"8","key":"2908_CR5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2(8):584\u2013593","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"2908_CR6","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350(16):1655\u20131664","journal-title":"N Engl J Med"},{"issue":"3","key":"2908_CR7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1586\/ecp.12.21","volume":"5","author":"JA Ford","year":"2012","unstructured":"Ford JA, Mowatt G, Jones R (2012) Assessing pharmacological interventions for bone metastases: the need for more patient-centered outcomes. Expert Rev Clin Pharmacol 5(3):271\u2013279","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"2908_CR8","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z","volume":"88","author":"A Lipton","year":"2000","unstructured":"Lipton A, Theriault RL, Hortobagyi GN, Simeone J, Knight RD, Mellars K, Reitsma DJ, Heffernan M, Seaman JJ (2000) Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer 88(5):1082\u20131090","journal-title":"Cancer"},{"issue":"11","key":"2908_CR9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/jnci\/djh141","volume":"96","author":"F Saad","year":"2004","unstructured":"Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Zheng M, Zoledronic Acid Prostate Cancer Study Group (2004) Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 96(11):879\u2013882","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"2908_CR10","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/cncr.20308","volume":"100","author":"LS Rosen","year":"2004","unstructured":"Rosen LS, Gordon D, Tchekmedyian NS, Yanagihara R, Hirsh V, Krzakowski M, Pawlicki M, De Souza P, Zheng M, Urbanowitz G, Reitsma D, Seaman J (2004) Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial. Cancer 100(12):2613\u20132621","journal-title":"Cancer"},{"issue":"3","key":"2908_CR11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10147-012-0414-8","volume":"18","author":"L Costa","year":"2013","unstructured":"Costa L, Lipton A, Hadji P, Chen YM, Kosmidis P (2013) Treatment of bone metastases before the onset of pain. Int J Clin Oncol 18(3):531\u2013538","journal-title":"Int J Clin Oncol"},{"issue":"20 Pt 2","key":"2908_CR12","doi-asserted-by":"crossref","first-page":"6236s","DOI":"10.1158\/1078-0432.CCR-06-0988","volume":"12","author":"CS Cleeland","year":"2006","unstructured":"Cleeland CS (2006) The measurement of pain from metastatic bone disease: capturing the patient\u2019s experience. Clin Cancer Res 12(20 Pt 2):6236s\u20136242s","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2908_CR13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/AJP.0b013e3181f3f667","volume":"27","author":"K Lemay","year":"2011","unstructured":"Lemay K, Wilson KG, Buenger U, Jarvis V, Fitzgibbon E, Bhimji K, Dobkin PL (2011) Fear of pain in patients with advanced cancer or in patients with chronic noncancer pain. Clin J Pain 27(2):116\u2013124","journal-title":"Clin J Pain"},{"issue":"4","key":"2908_CR14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/cncr.27789","volume":"119","author":"CS Cleeland","year":"2013","unstructured":"Cleeland CS, Body JJ, Stopeck A, von Moos R, Fallowfield L, Mathias SD, Patrick DL, Clemons M, Tonkin K, Masuda N, Lipton A, de Boer R, Salvagni S, Oliveira CT, Qian Y, Jiang Q, Dansey R, Braun A, Chung K (2013) Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer 119(4):832\u2013838","journal-title":"Cancer"},{"issue":"1","key":"2908_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/annonc\/mdm555","volume":"19","author":"M Maltoni","year":"2008","unstructured":"Maltoni M (2008) Opioids, pain, and fear. Ann Oncol 19(1):5\u20137","journal-title":"Ann Oncol"},{"issue":"3","key":"2908_CR16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ncponc1323","volume":"6","author":"L Costa","year":"2009","unstructured":"Costa L, Major PP (2009) Effect of bisphosphonates on pain and quality of life in patients with bone metastases. Nat Clin Pract Oncol 6(3):163\u2013174","journal-title":"Nat Clin Pract Oncol"},{"issue":"9","key":"2908_CR17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJM199403033300902","volume":"330","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ (1994) Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330(9):592\u2013596","journal-title":"N Engl J Med"},{"issue":"12","key":"2908_CR18","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s00520-013-1932-2","volume":"21","author":"R Moos von","year":"2013","unstructured":"von Moos R, Body JJ, Egerdie B, Stopeck A, Brown JE, Damyanov D, Fallowfield LJ, Marx G, Cleeland CS, Patrick DL, Palazzo FG, Qian Y, Braun A, Chung K (2013) Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer 21(12):3497\u20133507","journal-title":"Support Care Cancer"},{"issue":"8","key":"2908_CR19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00520-008-0418-0","volume":"16","author":"L Costa","year":"2008","unstructured":"Costa L, Badia X, Chow E, Lipton A, Wardley A (2008) Impact of skeletal complications on patients\u2019 quality of life, mobility, and functional independence. Support Care Cancer 16(8):879\u2013889","journal-title":"Support Care Cancer"},{"issue":"35","key":"2908_CR20","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","volume":"28","author":"AT Stopeck","year":"2010","unstructured":"Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, de Boer RH, Lichinitser M, Fujiwara Y, Yardley DA, Viniegra M, Fan M, Jiang Q, Dansey R, Jun S, Braun A (2010) Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 28(35):5132\u20135139","journal-title":"J Clin Oncol"},{"issue":"9768","key":"2908_CR21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","volume":"377","author":"K Fizazi","year":"2011","unstructured":"Fizazi K, Carducci M, Smith M, Dami\u00e4o R, Brown J, Karsh L, Milecki P, Shore N, Rader M, Wang H, Jiang Q, Tadros S, Dansey R, Goessl C (2011) Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 377(9768):813\u2013822","journal-title":"Lancet"},{"issue":"9","key":"2908_CR22","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","volume":"29","author":"DH Henry","year":"2011","unstructured":"Henry DH, Costa L, Goldwasser F, Hirsh V, Hungria V, Prausova J, Scagliotti GV, Sleeboom H, Spencer A, Vadhan-Raj S, von Moos R, Willenbacher W, Woll PJ, Wang J, Jiang Q, Jun S, Dansey R, Yeh H (2011) Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 29(9):1125\u20131132","journal-title":"J Clin Oncol"},{"issue":"3","key":"2908_CR23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00520-013-2022-1","volume":"22","author":"D Henry","year":"2014","unstructured":"Henry D, Vadhan-Raj S, Hirsh V, von Moos R, Hungria V, Costa L, Woll PJ, Scagliotti G, Smith G, Feng A, Jun S, Dansey R, Yeh H (2014) Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors. Support Care Cancer 22(3):679\u2013687","journal-title":"Support Care Cancer"},{"issue":"12","key":"2908_CR24","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/JTO.0b013e31826aec2b","volume":"7","author":"GV Scagliotti","year":"2012","unstructured":"Scagliotti GV, Hirsh V, Siena S, Henry DH, Woll PJ, Manegold C, Solal-Celigny P, Rodriguez G, Krzakowski M, Mehta ND, Lipton L, Garcia-Saenz JA, Pereira JR, Prabhash K, Ciuleanu TE, Kanarev V, Wang H, Balakumaran A, Jacobs I (2012) Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study. J Thorac Oncol 7(12):1823\u20131829","journal-title":"J Thorac Oncol"},{"key":"2908_CR25","unstructured":"XGEVA\u00ae [package insert]. Thousand Oaks, CA: Amgen Inc. http:\/\/pi.amgen.com\/united_states\/xgeva\/xgeva_pi.pdf . Accessed 31 March 2014"},{"issue":"16","key":"2908_CR26","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","volume":"48","author":"A Lipton","year":"2012","unstructured":"Lipton A, Fizazi K, Stopeck AT, Henry DH, Brown JE, Yardley DA, Richardson GE, Siena S, Maroto P, Clemens M, Bilynskyy B, Charu V, Beuzeboc P, Rader M, Viniegra M, Saad F, Ke C, Braun A, Jun S (2012) Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials. Eur J Cancer 48(16):3082\u20133092","journal-title":"Eur J Cancer"},{"issue":"2","key":"2908_CR27","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM (1994) Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap 23(2):129\u2013138","journal-title":"Ann Acad Med Singap"},{"key":"2908_CR28","unstructured":"Cleeland CS (2009) The brief pain inventory user guide. The University of Texas MD. Anderson Cancer Center, Houston. http:\/\/www.mdanderson.org\/education-and-research\/departments-programs-and-labs\/departments-and-divisions\/symptom-research\/symptom-assessment-tools\/BPI_UserGuide.pdf . Accessed 31 March 2014."},{"issue":"2","key":"2908_CR29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/pme.12299","volume":"15","author":"KC Chung","year":"2014","unstructured":"Chung KC, Barlev A, Braun AH, Qian Y, Zagari M (2014) Assessing analgesic use in patients with advanced cancer: development of a new scale\u2014the Analgesic Quantification Algorithm. Pain Med 15(2):225\u2013232","journal-title":"Pain Med"},{"issue":"3","key":"2908_CR30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570\u2013579","journal-title":"J Clin Oncol"},{"key":"2908_CR31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","volume":"1","author":"K Webster","year":"2003","unstructured":"Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 1:79","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"2908_CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/pcan.2011.7","volume":"14","author":"N Sathiakumar","year":"2011","unstructured":"Sathiakumar N, Delzell E, Morrisey MA, Falkson C, Yong M, Chia V, Blackburn J, Arora T, Kilgore ML (2011) Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999\u20132006. Prostate Cancer Prostatic Dis 14(2):177\u2013183","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"2908_CR33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-011-1721-x","volume":"131","author":"N Sathiakumar","year":"2012","unstructured":"Sathiakumar N, Delzell E, Morrisey MA, Falkson C, Yong M, Chia V, Blackburn J, Arora T, Brill I, Kilgore ML (2012) Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006. Breast Cancer Res Treat 131(1):231\u2013238","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2908_CR34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eururo.2014.10.001","volume":"68","author":"K Fizazi","year":"2015","unstructured":"Fizazi K, Massard C, Smith M, Rader M, Brown J, Milecki P, Shore N, Oudard S, Karsh L, Carducci M, Damiao R, Wang H, Ying W, Goessl C (2015) Bone-related parameters are the main prognostic factors for overall survival in men with bone metastases from castration-resistant prostate cancer. Eur Urol 68(1):42\u201350","journal-title":"Eur Urol"},{"issue":"2","key":"2908_CR35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10549-011-1475-5","volume":"129","author":"M Yong","year":"2011","unstructured":"Yong M, Jensen AO, Jacobsen JB, Norgaard M, Fryzek JP, Sorensen HT (2011) Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999-2007). Breast Cancer Res Treat 129(2):495\u2013503","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2908_CR36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.juro.2010.03.034","volume":"184","author":"M Norgaard","year":"2010","unstructured":"Norgaard M, Jensen AO, Jacobsen JB, Cetin K, Fryzek JP, Sorensen HT (2010) Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol 184(1):162\u2013167","journal-title":"J Urol"},{"issue":"2","key":"2908_CR37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.lungcan.2014.08.022","volume":"86","author":"K Cetin","year":"2014","unstructured":"Cetin K, Christiansen CF, Jacobsen JB, Norgaard M, Sorensen HT (2014) Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study. Lung Cancer 86(2):247\u2013254","journal-title":"Lung Cancer"},{"issue":"2","key":"2908_CR38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1470-2045(13)70581-3","volume":"15","author":"C Nieder","year":"2014","unstructured":"Nieder C (2014) Repeat palliative radiotherapy for painful bone metastases. Lancet Oncol 15(2):126\u2013128","journal-title":"Lancet Oncol"},{"issue":"2","key":"2908_CR39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1470-2045(13)70556-4","volume":"15","author":"E Chow","year":"2014","unstructured":"Chow E, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, Brundage MD, Nabid A, Tissing-Tan CJ, Oei B, Babington S, Demas WF, Wilson CF, Meyer RM, Chen BE, Wong RK (2014) Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol 15(2):164\u2013171","journal-title":"Lancet Oncol"},{"issue":"4 suppl","key":"2908_CR40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1200\/jco.2014.32.4_suppl.35","volume":"32","author":"MR Smith","year":"2014","unstructured":"Smith MR, Coleman RE, Klotz L, Pittman KB, Milecki P, Wei R, Balakumaran A, Fizazi K (2014) Denosumab for the prevention of symptomatic skeletal events in patients with castration-resistant advanced prostate cancer: a comparison with skeletal-related events. J Clin Oncol 32(4 suppl):35","journal-title":"J Clin Oncol"},{"key":"2908_CR41","volume-title":"Prevalence of and factors associated with skeletal-related events in older United States women diagnosed with metastatic breast cancer","author":"A Hussain","year":"2014","unstructured":"Hussain A, Yong C, Tkaczuk K, Qian Y, Arellano J, Balakumaran A, Liede A, Mullins CD, Onukwugha E (2014) Prevalence of and factors associated with skeletal-related events in older United States women diagnosed with metastatic breast cancer. Poster presented at: MASCC\/ISOO International Symposium on Supportive Care in Cancer; June 26\u201328, 2014, Miami, FL, USA"},{"key":"2908_CR42","volume-title":"Burden and timing of first and subsequent skeletal related events (SREs) in US elderly men with metastatic prostate cancer","author":"AM Abdulhalim","year":"2014","unstructured":"Abdulhalim AM, Hussain A, Mullins CD, Qian Y, Arellano J, Balakumaran A, Onukwugha E (2014) Burden and timing of first and subsequent skeletal related events (SREs) in US elderly men with metastatic prostate cancer. Presented at: International Society for Pharmacoeconomics and Outcomes Research; May 31-June 4, 2014, Montreal, QC, Canada"},{"issue":"12","key":"2908_CR43","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1007\/s00520-013-1887-3","volume":"21","author":"G Oster","year":"2013","unstructured":"Oster G, Lamerato L, Glass AG, Richert-Boe KE, Lopez A, Chung K, Richhariya A, Dodge T, Wolff GG, Balakumaran A, Edelsberg J (2013) Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Support Care Cancer 21(12):3279\u20133286","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2908-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-015-2908-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2908-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T18:51:52Z","timestamp":1553626312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-015-2908-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["2908"],"URL":"https:\/\/doi.org\/10.1007\/s00520-015-2908-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}